Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention
Read More Healthcare Industry News Zimmer Biomet expands foot and ankle portfolio with $1.2bn Paragon 28 acquisition Zimmer Biomet Holdings, Inc. has entered into a definitive agreement to acquire Paragon 28, Inc., a leading medical… byPallavi MadhirajuJanuary 29, 2025